Methods for treatment of chronic thyroid eye disease

TW202639164APending Publication Date: 2026-10-01VIRIDIAN THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149201
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-02-25
Filing Date
2025-12-15
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078808_001
    Figure TWG2TA001078808_001
  • Figure TWG2TA001078808_002
    Figure TWG2TA001078808_002
  • Figure TWG2TA001078808_003
    Figure TWG2TA001078808_003
Patent Text Reader

Abstract

The present invention provides, among other things, a method of treating chronic thyroid eye disease (TED) comprising administering an anti-IGF-1R antibody to a patient at a dosing regimen for a treatment period sufficient to reduce one or more symptoms associated with TED with low adverse events, such as hearing impairment.
Need to check novelty before this filing date? Find Prior Art